2020
Statement relating to the Report from the CMDh meeting, 24-26 March 2020
Discussion to date: April 2020
COVID-19 outbreak and user testing of package leaflets
2019
Statement relating to the ePI intended for use in the European Union
Discussion to date: January 2019
2015
Statement relating to the Excipients Guideline draft on sodium laurilsulfate
Discussion to date: September 2015
Excipients Guideline draft on sodium laurilsulfate - September 2015 (PDF)
Statement relating to the Excipients Guideline draft on sodium
Discussion to date: May 2015
Excipients Guideline draft on sodium - May 2015 (PDF)
2012
Statement relating to the QRD template draft
Discussion to date: July 2012
QRD template draft - July 2012 (PDF)
Statement relating to the QRD template draft
Discussion to date: April 2012
QRD template draft - April 2012 (PDF)
2010
2nd statement relating to the QRD template draft
Discussion to date: October 2010
QRD template - draft February 2010 (PDF)
1st statement relating to the QRD template draft
Discussion to date: February 2010
QRD template - draft February 2010 (PDF)
2007
Proposals to optimise the German QRD template
German QRD Template: Discussion and proposals to date - June 2007
2006
Statement relating to the IQWIG health information draft
Discussion to date: October 2006
Statement relating to the Readability Guideline draft 2006
Discussion to date: September 2006
Guideline on the readability of the label and package leaflet of medicinal products for human use - Draft (PDF)
Statement relating to the draft: 2nd proclamation of the revised version regarding the recommendations for package insert design according to paragraph 11 of the German drug law for human pharmaceuticals
Discussion to date: April 2006